Cellectis (CLLS) Interest Coverage Ratio (2015 - 2026)
Cellectis (CLLS) posted quarterly Interest Coverage Ratio of 5.66 for Q1 2026, up 309.23% year-over-year from 1.38 in Q1 2025, and up 3060.88% quarter-over-quarter from 0.19 in Q4 2025.
Cellectis (CLLS) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Cellectis' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 5.66 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 309.23% year-over-year to 5.66; the TTM figure through Mar 2026 stood at 0.79 (up 94.96% YoY), while the FY2025 annual figure was 1.17, up 57.67% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 5.66, up from 0.19 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 25.14 in Q3 2022, with the low at 0.9 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 1.03 (2024), against an average of 4.82.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio slumped 205.43% in 2025, then jumped 309.23% in 2026.
- Cellectis' Interest Coverage Ratio stood at 0.26 in 2022, then slumped by 80.04% to 0.46 in 2023, then soared by 49.61% to 0.23 in 2024, then rose by 18.22% to 0.19 in 2025, then soared by 3060.88% to 5.66 in 2026.
- Business Quant data shows CLLS's Interest Coverage Ratio at 5.66 in Q1 2026, 0.19 in Q4 2025, and 0.74 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | 5.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.66 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 1.38 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 1.03 |
| Mar 31, 2024 | 6.66 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.90 |
| Jun 30, 2023 | 1.45 |
| Mar 31, 2023 | 4.53 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | 25.14 |
| Jun 30, 2022 | 16.15 |
| Mar 31, 2022 | 21.52 |
| Dec 31, 2021 | -4.29 |
| Sep 30, 2021 | -19.37 |
| Jun 30, 2021 | 28.57 |